Advertisement NAFLD/NASH Medications Tweet × Share Twitter Facebook Pinterest Tumblr Email Copy Link Share Print The NAFLD/NASH medications' page includes specific information about each of the experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Quick Links NAFLD/NASH Medications Quick Filter Select list: Select Drug TAK-652, TBR-652 GFT505 OCA GS-4997 IDN-6556, PF-03491390 GS-9674 GS-0976 BMS-986036 LJN452 *generic or biosimilar available E experimental NAFLD/NASH Medications Learn more >> More >> DRUG ABBRV. GENERIC NAME E cenicriviroc CVC cenicriviroc E elafibranor N/A elafibranor E Ocaliva OCA obeticholic acid E selonsertib N/A selonsertib E emricasan N/A emricasan E cilofexor N/A N/A E firsocostat N/A N/A E pegbelfermin N/A pegbelfermin E tropifexor N/A tropifexor Multi-Class Combination Drugs More >> DRUG cenicriviroc E ABBRV. CVC GENERIC NAME cenicriviroc DRUG elafibranor E ABBRV. N/A GENERIC NAME elafibranor DRUG Ocaliva E ABBRV. OCA GENERIC NAME obeticholic acid DRUG selonsertib E ABBRV. N/A GENERIC NAME selonsertib DRUG emricasan E ABBRV. N/A GENERIC NAME emricasan DRUG cilofexor E ABBRV. N/A GENERIC NAME N/A DRUG firsocostat E ABBRV. N/A GENERIC NAME N/A DRUG pegbelfermin E ABBRV. N/A GENERIC NAME pegbelfermin DRUG tropifexor E ABBRV. N/A GENERIC NAME tropifexor Read More About: #Bristol Myers Squibb #Cenicriviroc #fatty liver disease #Gilead Sciences #NASH #Novartis #NAFLD #Selonsertib #Elafibranor #Emricasan #Pegbelfermin #Ocaliva #Intercept Pharmaceuticals #Genfit #firsocostat #cilofexor #tropifexor Advertisement RELATED articles FDA Delays Approval of Ocaliva for Fatty Liver Disease Fatty Liver Disease Is Less Common but More Severe in Women Fatty Liver Disease Tied to Reduced Capacity for Exertion in Adolescents Even Lean People With HIV Can Get Fatty Liver Disease
